Bulk Drug Intermediates

Chemcrux Enterprises reported unaudited Q1 FY27 standalone net profit of ₹13.74 crore, up from ₹5.85 crore YoY. Total standalone income for the quarter was ₹222.47 crore with profit before tax of ₹185